Region Vaestmanland — Clinical Trial Site

9 Registered trials

3 Currently recruiting

Organisation

Region Vaestmanland

Location

Vasteras, Sweden

Identifier

ORG-100042462

Address

Sigtunagatan, 721 89, Sweden

Departments

Barnkliniken - Pediatrisk gastroenterologi, hepatologi och nutrition, Västmanlands Sjukhus Västerås
Department of Oncology
Department of Ophtalmology, Västmanlands sjukhus Västerås, Sigtunagatan, 721 89 Västerås
Hjärtmottagningen, Västmanlands sjukhus
Hjärtmottagningen, Västmanlands sjukhus Västerås
Medicinkliniken, Hjärtmottagningen
NA
Reumatologisk klinik, Västerås sjukhus
Västmanland Hospital, Sigtunagatan, 721 89 Västerås

Clinical trials at this site (9)

Search interface

Crohn's Disease: Pharmacokinetics, Efficacy, and Safety of Risankizumab in Pediatric Subjects with Moderately to Severely Active Crohn's Dis… Recruiting

2022-502050-14-00 Crohn's disease 5 2024-06-04
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting

2023-507164-39-00 Induction of labour 6 2021-12-01
EVOLVE-MI Ended

2023-509268-26-00 Dyslipidemia 6 2024-01-08
A Randomized Intervention, Multi-Center Study to Determine the Role of Dexamethasone eye drops against proliferative retinopathy of prematur… Ended

2023-505318-97-00 Retinopathy of Prematurity 5 2022-09-22
Efficacy, tolerability and preferences of per oral or subcutaneous methotrexate in patients with early rheumatoid arthritis – a randomised r… Ended

2024-512453-25-00 Rheumatoid arthritis 6 2022-04-28
A translational RANDOMIZED phase III study exploring the effect of the addition of capecitabine to Carboplatinum based chemotherapy in early… Ended

2022-501102-35-00 Early triple negative breast cancer 5 2019-12-02
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Ended

2022-500881-80-00 Chronic Heart Failure With Reduced Ejection Fraction 5 2021-10-29